Fresh Tracks Therapeutics Inc (FRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,868 | 8,680 | 26,884 | 30,115 | 7,232 |
| Marketable Securities | N/A | N/A | N/A | N/A | 4,497 |
| TOTAL | $11,552 | $10,083 | $29,600 | $33,530 | $17,969 |
| Non-Current Assets | |||||
| PPE Net | 34 | 75 | 58 | 30 | 16 |
| Other Non-Current Assets | 0 | 113 | 59 | 74 | 159 |
| TOTAL | $34 | $188 | $117 | $104 | $175 |
| Total Assets | $11,586 | $10,271 | $29,717 | $33,634 | $18,144 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 406 | 571 | 1,605 | 568 | 2,245 |
| Accrued Expenses | 1,250 | 2,457 | 3,136 | 5,420 | 6,379 |
| TOTAL | $1,656 | $3,077 | $4,810 | $6,353 | $10,497 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 1,795 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 146 | 73 |
| TOTAL | $N/A | $N/A | $N/A | $146 | $73 |
| Total Liabilities | $1,656 | $3,077 | $4,810 | $6,499 | $10,570 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,973 | 5,906 | 2,650 | 1,486 | 215 |
| Common Shares | 60 | 30 | 27 | 536 | 85 |
| Retained earnings | -172,163 | -166,469 | -145,367 | -105,893 | -84,980 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -28 |
| TOTAL | $9,930 | $7,194 | $24,907 | $27,135 | $7,574 |
| Total Liabilities And Equity | $11,586 | $10,271 | $29,717 | $33,634 | $18,144 |